Klinikum Kassel GmbH — Clinical Trial Site

67 Registered trials

37 Currently recruiting

Organisation

Klinikum Kassel GmbH

Location

Kassel, Germany

Identifier

ORG-100040751

Address

Moenchebergstrasse 41-43, Fasanenhof, 34125, Germany

Departments

Abteilung Klinik für Hämatologie und Onkologie
Clinic for Hematology, Oncology and Immunology
Department of Gynaecology and Obstetrics
Department of Neurology
Dept. for Hematology, Oncology and Immunology
Frauenklinik
Frauenklinik, Gynäkologie
Gesundheit Nordhessen, Holding AG Klinik für pädiatrische Hämatologie und Onkologie
Gynaecology
Gynäkologie des MVZ Gesundheit Nordhessen
Gynecology and obstetrics
Hämatologie, Onkologie und Immunologie
Hematology, Oncology and Immunology Clinic
Kinderklinik f. päd. Hämato-Onkologie, Psychosomatik und Systemerkrankungen
Klinik fuer Haematologie, Onkologie und Immunologie
Klinik für Dermatologie
Klinik für Frauenheilkunde und Geburtshilfe
Klinik für Haematologie Onkologie und Immunologie
Klinik für Haematologie, Onkologie und Immunologie
Klinik für Hals-Nasen-Ohrenheilkunde
Klinik für Hämatologie und Onkologie
Klinik für Hämatologie, Onkologie und Immunologie
Klinik für Innere Medizin, Hämatologie, Onkologie und Immunologie
Klinik für Neurologie
Klinik für Päd. Hämato-Onkologie, Psychosomatik und Systemerkrankungen
Klinik für Päd. Hämatologie und Onkologie
Klinik für pädiatrische Hämato-Onkologie, Psychosomatik und Systemerkrankungen
Klinik für Pädiatrische Hämatologie und Onkologie
Klinikum Kassel Klinik für Frauenheilkunde und Geburtshilfe
N/A
NA
Päd. Hämatologie und Onkologi
Pädiatrische Hämatologie und Onkologie
Paedriatrics, Department of Oncology and Hematology
Pediatric hematology and oncology
Pediatric hematology/oncology
Women’s Clinic

Clinical trials at this site (67)

Search interface

This study is to find out about the Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) compared to R2 in… Ended

2023-505628-67-00 Relapsed and Refractory Follicular Lymphoma 5 2022-10-28
A phase II, open-label, single arm study to evaluate the efficacy of Luspatercept in Erythropoiesis-stimulating agent naive lower-risk MDS p… Ended

2024-516438-36-00 Patients with very low, low or intermediate risk myelod 4 2022-09-13
Combination of Abemaciclib and endocrine therapy in hormone receptor positive HER2 negative locally advanced or metastatic breast cancer wit… Ended

2024-511209-49-00 Patients with hormone receptor positive HER2 negative l 6 2022-04-26
Trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to standard therapy versus standard therapy in patients… Ended

2022-500237-92-00 Newly-diagnosed high-intermediate and high-risk diffuse 5 2021-04-23
A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Alone and in Combination With Ruxolitinib in Participants Wit… Ended

2023-507274-40-00 Myelofibrosis 3 2021-04-22
A study on the efficacy and safety of cisplatin/etoposide and concomitant radiotherapy in combination with durvalumab, an immunotherapy, in … Ended

2024-513433-20-00 Limited Disease Small Cell Lung Cancer 4 2020-12-16
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours Ended

2023-507582-25-00 Malignant Extracranial Germ Cell Tumours (MGCT) 5 2019-08-02
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk… Ended

2024-515769-32-00 HR+/HER2- early breast cancer 5 2019-07-02
Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell … Ended

2023-507902-15-00 Non-Small Cell Lung Cancer 4 2019-03-26
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia Ended

2023-509856-32-00 acute lymphoblastic leukemia in children and adolescent 5 2018-07-15
International Study for Treatment of High Risk Childhood Relapsed ALL 2010 - A randomized Phase II Study Conducted by the Resistant Disease … Ended

2024-513070-21-00 Relapsed Acute Lymphoblastic Leukemia (ALL) 4 2018-02-15
International trial in Philadelphia chromosome-positive acute lymphoblastic leukemia Ended

2024-515499-12-00 Acute lymphoblastic leukemia 5 2017-10-02
B-NHL 2013 - Treatment protocol of the NHL-BFM and the NOPHO study groups for mature aggressive B-cell lymphoma and leukemia in children and… Ended

2023-505509-18-00 mature aggressive B-cell lymphoma and leukemia in child 5 2017-07-12
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed S… Ended

2024-513559-34-00 Small Cell Lung Cancer (SCLC) 5 2022-07-19
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04
This is a phase III randomised, double-blind, placebo-controlled, multicentre, global study to assess the effectiveness and safety of standa… Ended

2022-502747-35-00 Newly diagnosed advanced (FIGO stage III-IV) high grade 5 2019-02-18
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13
Surgical or radiotherapeutic intervention concerning large singular stable to progressive metastases in patients with BRAFV600-mutated melan… Ended

2024-516073-74-00 Unresectable or metastatic melanoma with a BRAF V600 mu 6